| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Assessing the Clinical Utility of Published Prostate Cancer Polygenic Risk Scores in a Large Biobank Data Set
|
Vince Jr, Randy A.
|
|
|
8 |
1 |
p. 47-55
|
artikel
|
| 2 |
Association Between Hypoglycemia Agents and Long-term Survival Outcomes for Patients with Non–muscle-invasive Bladder Cancer Treated with Intravesical Bacillus Calmette-Guérin Immunotherapy
|
Liu, Kang
|
|
|
8 |
1 |
p. 164-170
|
artikel
|
| 3 |
Combination of Abiraterone Acetate, Prostate Bed Radiotherapy, and Luteinizing Hormone-releasing Hormone Agonists in Biochemically Relapsing Patients After Prostatectomy (CARLHA): A Phase 2 Clinical Trial
|
Ah-Thiane, Loic
|
|
|
8 |
1 |
p. 38-46
|
artikel
|
| 4 |
Comparison of Pathologist and Artificial Intelligence–based Grading for Prediction of Metastatic Outcomes After Radical Prostatectomy
|
Oliveira, Lia D.
|
|
|
8 |
1 |
p. 9-13
|
artikel
|
| 5 |
Consistencies in Follow-up After Radical Cystectomy for Bladder Cancer: A Framework Based on Expert Practices Collaboratively Developed by the European Association of Urology Bladder Cancer Guideline Panels
|
Mertens, Laura S.
|
|
|
8 |
1 |
p. 105-110
|
artikel
|
| 6 |
Contents
|
|
|
|
8 |
1 |
p. iii-vii
|
artikel
|
| 7 |
Deintensification of Treatment for Low-grade Bladder Tumors: A Collaborative Review by the International Bladder Cancer Group (IBCG)
|
Contieri, Roberto
|
|
|
8 |
1 |
p. 179-189
|
artikel
|
| 8 |
Digital Twins in Urological Oncology: Precise Treatment Planning via Complex Modeling
|
Checcucci, Enrico
|
|
|
8 |
1 |
p. 1-4
|
artikel
|
| 9 |
Editorial Board
|
|
|
|
8 |
1 |
p. i-ii
|
artikel
|
| 10 |
Effectiveness and Cost-effectiveness of Artificial Intelligence–assisted Pathology for Prostate Cancer Diagnosis in Sweden: A Microsimulation Study
|
Du, Xiaoyang
|
|
|
8 |
1 |
p. 80-86
|
artikel
|
| 11 |
Expert Consensus Recommendations on the Management of Treatment-emergent Adverse Events Among Men with Prostate Cancer Taking Poly-ADP Ribose Polymerase Inhibitor + Novel Hormonal Therapy Combination Therapy
|
Shore, Neal D.
|
|
|
8 |
1 |
p. 94-104
|
artikel
|
| 12 |
Frailty and Renal Cell Carcinoma: Integration of Comprehensive Geriatric Assessment into Shared Decision-making
|
Pecoraro, Alessio
|
|
|
8 |
1 |
p. 190-200
|
artikel
|
| 13 |
Frailty in Older Adults with Prostate Cancer
|
Pathak, Neha
|
|
|
8 |
1 |
p. 14-20
|
artikel
|
| 14 |
Functional Outcomes and Quality of Life in High-risk Prostate Cancer Patients Treated by Robot-assisted Radical Prostatectomy with or Without Adjuvant Treatments
|
Devlies, Wout
|
|
|
8 |
1 |
p. 56-65
|
artikel
|
| 15 |
Genomic Determinants Associated with Modes of Progression and Patterns of Failure in Metachronous Oligometastatic Castration-sensitive Prostate Cancer
|
Sutera, Philip
|
|
|
8 |
1 |
p. 111-118
|
artikel
|
| 16 |
Hall of Fame
|
|
|
|
8 |
1 |
p. viii
|
artikel
|
| 17 |
Health-related Quality of Life Assessment in Renal Cell Cancer: A Scoping Review
|
Gross, Franziska
|
|
|
8 |
1 |
p. 201-212
|
artikel
|
| 18 |
Hematuria Cancer Risk Score with Ultrasound Informs Cystoscopy Use in Patients with Hematuria
|
Tan, Wei Shen
|
|
|
8 |
1 |
p. 87-93
|
artikel
|
| 19 |
Incidental Prostate Cancer in Patients Undergoing Surgery for Benign Prostatic Hyperplasia: A Predictive Model
|
Anract, Julien
|
|
|
8 |
1 |
p. 145-151
|
artikel
|
| 20 |
Liquid Biopsy in Progressing Prostate Cancer Patients Starting Docetaxel with or Without Enzalutamide: A Biomarker Study of the PRESIDE Phase 3b Trial
|
Ruiz-Vico, Maria
|
|
|
8 |
1 |
p. 135-144
|
artikel
|
| 21 |
Management of Small Testicular Masses: A Delphi Consensus Study
|
Pang, Karl H.
|
|
|
8 |
1 |
p. 152-163
|
artikel
|
| 22 |
Pain and Health-related Quality of Life with Biweekly Versus Triweekly Cabazitaxel Schedule in Older Men with Metastatic Castration-resistant Prostate Cancer in the Multicenter, Randomized CABASTY Trial
|
Oudard, Stephane
|
|
|
8 |
1 |
p. 126-134
|
artikel
|
| 23 |
Patient-reported Quality of Life and Survival Outcomes in Prostate Cancer: Analysis of the ECOG-ACRIN E3805 Chemohormonal Androgen Ablation Randomized Trial (CHAARTED)
|
Sentana-Lledo, Daniel
|
|
|
8 |
1 |
p. 29-37
|
artikel
|
| 24 |
Phase 2 Study of Preoperative Tislelizumab in Combination with Low-dose Nab-Paclitaxel in Patients with Muscle-invasive Bladder Cancer
|
Wu, Zhouliang
|
|
|
8 |
1 |
p. 66-72
|
artikel
|
| 25 |
Re: Julien Anract, Clément Klein, Ugo Pinar, Morgan Rouprêt, Nicolas Barry Delongchamps, Grégoire Robert. Incidental Prostate Cancer in Patients Undergoing Surgery for Benign Prostatic Hyperplasia: A Predictive Model. Eur Urol Oncol. 2025;8:145–51
|
Leni, Riccardo
|
|
|
8 |
1 |
p. 215
|
artikel
|
| 26 |
Reply to Riccardo Leni, Andreas Roder, and Hein V. Stroomberg’s Letter to the Editor re: Julien Anract, Clément Klein, Ugo Pinar, Morgan Rouprêt, Nicolas Barry Delongchamps, Grégoire Robert. Incidental Prostate Cancer in Patients Undergoing Surgery for Benign Prostatic Hyperplasia: A Predictive Model. Eur Urol Oncol. 2025;8:145–51
|
Anract, Julien
|
|
|
8 |
1 |
p. 213-214
|
artikel
|
| 27 |
Short-term Darolutamide (ODM-201) Concomitant to Radiation Therapy for Patients with Unfavorable Intermediate-risk Prostate Cancer: The Darius (AFU-GETUG P15) Phase 2 Trial Protocol
|
Sargos, Paul
|
|
|
8 |
1 |
p. 73-79
|
artikel
|
| 28 |
Small Testicular Masses: An Individualized Approach Is Warranted
|
Heidenreich, Axel
|
|
|
8 |
1 |
p. 5-6
|
artikel
|
| 29 |
Time to Refine Prostate Cancer Epidemiology: Defining New Endpoints for Effective Screening and Causal Epidemiological Studies
|
Cussenot, Olivier
|
|
|
8 |
1 |
p. 7-8
|
artikel
|
| 30 |
Treatment-free Survival After First-line Therapies for Metastatic Renal Cell Carcinoma: An International Metastatic Renal Cell Carcinoma Database Consortium Analysis
|
Gupta, Mehul
|
|
|
8 |
1 |
p. 171-178
|
artikel
|
| 31 |
Treatment Related to Urinary Tract Infections Is Associated with Delayed Diagnosis of Urinary Bladder Cancer: A Nationwide Population-based Study
|
Liedberg, Fredrik
|
|
|
8 |
1 |
p. 119-125
|
artikel
|
| 32 |
Unmet Need in Non–muscle-invasive Bladder Cancer Failing Bacillus Calmette-Guérin Therapy: A Systematic Review and Cost-effectiveness Analyses from the International Bladder Cancer Group
|
D’Andrea, David
|
|
|
8 |
1 |
p. 216-229
|
artikel
|
| 33 |
Validation of Prognostic and Predictive Models for Therapeutic Response in Patients Treated with [177Lu]Lu-PSMA-617 Versus Cabazitaxel for Metastatic Castration-resistant Prostate Cancer (TheraP): A Post Hoc Analysis from a Randomised, Open-label, Phase 2 Trial
|
Gafita, Andrei
|
|
|
8 |
1 |
p. 21-28
|
artikel
|
Tijdschrift beschrijving